Summary
Mauricio Quezada is a translational biochemist and responsible researcher with 15 years of experience applying molecular and cellular biology to regenerative medicine, neurobiology, and addiction therapeutics. He has led multidisciplinary projects from bench to preclinical trials—optimizing MSC-derived extracellular vesicle production and advancing hMSC secretome therapies that reduced opioid consumption and relapse in animal models. His work spans high-precision analytical techniques (No-net-flux HPLC-FL, microdialysis), GLP/SOP development, and managing six-figure research budgets, paired with teaching and mentoring roles. A cofounder of cero.ai, he blends scientific rigor with an entrepreneurial mindset and a track record of publishing first-author studies from international fellowships. He is based in Santiago, Chile, and is driven by translating stem cell biology into scalable therapies for clinical impact.
14 years of coding experience
Bioquímico, Biochemistry, Distinción Máxima, Bioquímico, Biochemistry, Distinción Máxima at Universidad de Concepción
MSc and PhD (c), Ciencias e Innovación en Medicina, En Instituto de Ciencias e Innovación en medicina (ICIM), MSc and PhD (c), Ciencias e Innovación en Medicina, En Instituto de Ciencias e Innovación en medicina (ICIM) at Universidad del Desarrollo